Lexaria Bioscience Corp. (LEXX) at a glance

Lexaria Bioscience Corp. (LEXX) is a micro-cap Healthcare company. It trades at $0.55, with a 99.6% profit margin and revenue decline of 88.5%. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (94/100) and its weakest is Growth (12/100). It is a relatively defensive holding with below-market volatility.

Price

$0.55

Market cap

$15.2M

P/E ratio

n/a

Dividend yield

None

Beta

0.33

52-week range

$0.46 to $1.55